EAM

Exome Asset Management Portfolio holdings

AUM $110M
1-Year Est. Return 24.83%
This Quarter Est. Return
1 Year Est. Return
+24.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$110M
AUM Growth
-$1.32M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$4.75M
2
+$2.49M
3
+$2.48M
4
WAY
Waystar Holding Corp
WAY
+$1.92M
5
TXG icon
10x Genomics
TXG
+$1.9M

Top Sells

1
+$4.73M
2
+$3.09M
3
+$2.93M
4
SVRA icon
Savara
SVRA
+$2.32M
5
ANAB icon
AnaptysBio
ANAB
+$2.26M

Sector Composition

1 Healthcare 97.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
51
UnitedHealth
UNH
$328B
– –
0
VERU icon
52
Veru
VERU
$63.4M
– –
0
VRDN icon
53
Viridian Therapeutics
VRDN
$1.99B
– –
-217,294
ONC
54
BeOne Medicines Ltd
ONC
$34.6B
– –
-6,500
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$3.55B
– –
0
AKBA icon
56
Akebia Therapeutics
AKBA
$819M
– –
-189,087
AKRO icon
57
Akero Therapeutics
AKRO
$4.32B
– –
-76,379
ALDX icon
58
Aldeyra Therapeutics
ALDX
$315M
– –
0
ALT icon
59
Altimmune
ALT
$351M
– –
0
APRE icon
60
Aprea Therapeutics
APRE
$9.32M
– –
-28,972
ARVN icon
61
Arvinas
ARVN
$714M
– –
-195,295
AZN icon
62
AstraZeneca
AZN
$258B
– –
-32,534
BHVN icon
63
Biohaven
BHVN
$1.83B
– –
-39,900
COR icon
64
Cencora
COR
$63.1B
– –
0
GEHC icon
65
GE HealthCare
GEHC
$34.4B
– –
-25,400
IMNM icon
66
Immunome
IMNM
$1.4B
– –
-263,841
MREO
67
Mereo BioPharma
MREO
$342M
– –
0
NKTR icon
68
Nektar Therapeutics
NKTR
$1.15B
– –
-148,830
NUVB icon
69
Nuvation Bio
NUVB
$1.3B
– –
-96,311
OEF icon
70
iShares S&P 100 ETF
OEF
$27.2B
– –
0
RARE icon
71
Ultragenyx Pharmaceutical
RARE
$3.27B
– –
0
RDY icon
72
Dr. Reddy's Laboratories
RDY
$12.3B
– –
-117,500
ROIV icon
73
Roivant Sciences
ROIV
$12.1B
– –
0
RYTM icon
74
Rhythm Pharmaceuticals
RYTM
$7.36B
– –
0
SVRA icon
75
Savara
SVRA
$698M
– –
-836,397
1 2
3
4